Case of localized scleroderma successfully treated with bath psoralen and ultraviolet A therapy. 2010

Masaki Uchiyama, and Yukari Okubo, and Hisashi Kawashima, and Kengo Yamamoto, and Yoshihiko Mitsuhashi, and Ryoji Tsuboi
Department of Dermatology, Tokyo Medical University, Tokyo, Japan.

The patient was a 12-year-old girl with linear scleroderma distributed on the right abdomen, dorsal aspect of the right thigh, lower leg and foot. The initial regimen of oral prednisolone and methotrexate, or i.v. methylprednisolone failed in the treatment of the scleroderma. Then bath psoralen and ultraviolet A therapy (bath-PUVA) therapy of 0.2 J-4.0 J/cm(2) daily to total doses 62.8 J/cm(2) combined with oral prednisolone was started. After bath-PUVA therapy, regression of the skin sclerosis was observed, the possible mobile range of the right ankle was increased and histological examination confirmed improvement of the sclerosis. The successful results of bath-PUVA therapy in this case suggest its utility for localized scleroderma.

UI MeSH Term Description Entries
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D011701 PUVA Therapy Photochemotherapy using PSORALENS as the photosensitizing agent and ultraviolet light type A (UVA). Psoralen Ultraviolet A Therapy,Therapy, PUVA,PUVA Therapies,Therapies, PUVA
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D005355 Fibrosis Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury. Cirrhosis,Fibroses
D005363 Ficusin A naturally occurring furocoumarin, found in PSORALEA. After photoactivation with UV radiation, it binds DNA via single and double-stranded cross-linking. Psoralen,Psoralene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Masaki Uchiyama, and Yukari Okubo, and Hisashi Kawashima, and Kengo Yamamoto, and Yoshihiko Mitsuhashi, and Ryoji Tsuboi
July 2001, Journal of the European Academy of Dermatology and Venereology : JEADV,
Masaki Uchiyama, and Yukari Okubo, and Hisashi Kawashima, and Kengo Yamamoto, and Yoshihiko Mitsuhashi, and Ryoji Tsuboi
June 2010, The Journal of dermatology,
Masaki Uchiyama, and Yukari Okubo, and Hisashi Kawashima, and Kengo Yamamoto, and Yoshihiko Mitsuhashi, and Ryoji Tsuboi
April 2000, The British journal of dermatology,
Masaki Uchiyama, and Yukari Okubo, and Hisashi Kawashima, and Kengo Yamamoto, and Yoshihiko Mitsuhashi, and Ryoji Tsuboi
May 2000, Journal of the European Academy of Dermatology and Venereology : JEADV,
Masaki Uchiyama, and Yukari Okubo, and Hisashi Kawashima, and Kengo Yamamoto, and Yoshihiko Mitsuhashi, and Ryoji Tsuboi
October 2013, Photodermatology, photoimmunology & photomedicine,
Masaki Uchiyama, and Yukari Okubo, and Hisashi Kawashima, and Kengo Yamamoto, and Yoshihiko Mitsuhashi, and Ryoji Tsuboi
September 2014, Case reports in dermatology,
Masaki Uchiyama, and Yukari Okubo, and Hisashi Kawashima, and Kengo Yamamoto, and Yoshihiko Mitsuhashi, and Ryoji Tsuboi
May 2021, Dermatologic therapy,
Masaki Uchiyama, and Yukari Okubo, and Hisashi Kawashima, and Kengo Yamamoto, and Yoshihiko Mitsuhashi, and Ryoji Tsuboi
March 2024, Clinical case reports,
Masaki Uchiyama, and Yukari Okubo, and Hisashi Kawashima, and Kengo Yamamoto, and Yoshihiko Mitsuhashi, and Ryoji Tsuboi
January 2001, Journal of cutaneous medicine and surgery,
Masaki Uchiyama, and Yukari Okubo, and Hisashi Kawashima, and Kengo Yamamoto, and Yoshihiko Mitsuhashi, and Ryoji Tsuboi
April 2008, Journal of the European Academy of Dermatology and Venereology : JEADV,
Copied contents to your clipboard!